391 related articles for article (PubMed ID: 26248692)
1. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
Chew MF; Tham HW; Rajik M; Sharifah SH
J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial peptide HS-1 inhibits dengue virus infection.
Monteiro JMC; Oliveira MD; Dias RS; Nacif-Marçal L; Feio RN; Ferreira SO; Oliveira LL; Silva CC; Paula SO
Virology; 2018 Jan; 514():79-87. PubMed ID: 29153860
[TBL] [Abstract][Full Text] [Related]
3. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
4. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
7. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.
Hassandarvish P; Oo A; Jokar A; Zukiwski A; Proniuk S; Abu Bakar S; Zandi K
J Antimicrob Chemother; 2017 Sep; 72(9):2438-2442. PubMed ID: 28666323
[TBL] [Abstract][Full Text] [Related]
8. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
9. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
10. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
12. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
13. In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2.
Euanorasetr J; Intra B; Thunmrongsiri N; Limthongkul J; Ubol S; Anuegoonpipat A; Kurosu T; Ikuta K; Nihira T; Panbangred W
J Gen Appl Microbiol; 2019 Sep; 65(4):197-203. PubMed ID: 30814437
[TBL] [Abstract][Full Text] [Related]
14. Novel antiviral activity of bromocriptine against dengue virus replication.
Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
[TBL] [Abstract][Full Text] [Related]
15. Development of novel antiviral peptides against dengue serotypes 1-4.
Lee MF; Anasir MI; Poh CL
Virology; 2023 Mar; 580():10-27. PubMed ID: 36739680
[TBL] [Abstract][Full Text] [Related]
16. Carnosine exhibits significant antiviral activity against Dengue and Zika virus.
Rothan HA; Abdulrahman AY; Khazali AS; Nor Rashid N; Chong TT; Yusof R
J Pept Sci; 2019 Aug; 25(8):e3196. PubMed ID: 31290226
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
[TBL] [Abstract][Full Text] [Related]
19. Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu.
Panya A; Yongpitakwattana P; Budchart P; Sawasdee N; Krobthong S; Paemanee A; Roytrakul S; Rattanabunyong S; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2019 Feb; 93(2):100-109. PubMed ID: 30225997
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Screening Assays for Dengue Antiviral Drug Development.
Jabanathan SG; Xuan LZ; Ramanathan B
Methods Mol Biol; 2021; 2296():279-302. PubMed ID: 33977455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]